logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5153.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5153.produseast1
Towards a Patent Pool for HIV Medicines: The Background | Journal Article / Commentary | MSF Science Portal
Journal Article
|Commentary

Towards a Patent Pool for HIV Medicines: The Background

Childs M
Download

Similar Content
Loading...
Loading...
Loading...
Abstract
Recent WHO guidelines for antiretroviral therapy recommend switching to less toxic, but more expensive medicines for first-line and second-line ART, raising questions about the financial sustainability of many AIDS treatment programmes. At the same time, many key generic producing countries such as India now grant pharmaceutical product patents so competition between multiple manufacturers will not be able to play the role it has in bringing down the price of newer drugs.Overcoming these patent barriers will require a range of solutions, such as restricting patentability criteria, or compulsory licensing. One additional systematic solution is provided by the patent pool, a collective solution to the management of patent rights, initially presented by Médecins Sans Frontières to the French Foreign Ministry and subsequently the UNITAID Executive Board in 2006.A patent pool must not be implemented at any costs, but answer medical needs, be based on economic realities and meet the access needs of the developing world, including middle-income countries.

Countries

none

Subject Area

HIV/AIDSaccess to health care

Languages

English
DOI
10.2174/1874613601004020033
Published Date
19 Jan 2010
PubMed ID
20148090
Journal
Open AIDS journal
Volume | Issue | Pages
Volume 4, Issue 1
Issue Date
2010-01-19
Dimensions Badge